This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sullender, W M Articles by Chapman, S Search for Related Content PubMed PubMed Citation Articles by Sullender, W M Articles by Chapman, S

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1987 November; 31(11): 1722-1726

Pharmacokinetics of acyclovir suspension in infants and children.

W M Sullender, A M Arvin, P S Diaz, J D Connor, R Straube, W Dankner, M J Levin, S Weller, M R Blum and S Chapman

Department of Pediatrics, Stanford University School of Medicine, California 94305.

ABSTRACT

Eighteen children from 3 weeks to 6.9 years of age were given an oral acyclovir suspension for herpes simplex or varicella-zoster virus infections. Thirteen patients who were 6 months to 6.9 years old received 600 mg/m2 per dose, and three infants and two children less than 2 years old were given 300 mg/m2 per dose. The drug was given four times a day, except to one infant who was treated with three doses a day. Among the 13 children who received the 600-mg/m2 dose, the maximum concentration in plasma (Cmax) was 0.99 +/- 0.38 microgram/ml (mean +/- standard deviation), the time to maximum concentration (Tmax) was 3.0 +/- 0.86 h, the area under the curve (AUC) was 5.56 +/- 2.17 micrograms.h/ml, and the elimination half-life (t1/2) was 2.59 +/- 0.78 h. The three infants less than 2 months of age who received the 300-mg/m2 dose had a Cmax of 1.88 +/- 1.11 micrograms/ml, a Tmax of 4.10 +/- 0.48 h, an AUC of 6.54 +/- 4.32 micrograms.h/ml, and a t1/2 of 3.26 +/- 0.33 h. The acyclovir suspension was well tolerated by young children. No adverse effects requiring discontinuation of the drug occurred.

---

Antimicrob Agents Chemother. 1987 November; 31(11): 1722-1726

This article has been cited by other articles:

• Hudson, B, Powell, C (2009). QUESTION 1. Arch. Dis. Child. 94: 165-167 [Full Text]  
• Tod, M., Lokiec, F., Bidault, R., De Bony, F., Petitjean, O., Aujard, Y., the Acyclovir Pediatric French Group, (2001). Pharmacokinetics of Oral Acyclovir in Neonates and in Infants: a Population Analysis. Antimicrob. Agents Chemother. 45: 150-157 [Abstract] [Full Text]